Cornel iridoid glycoside attenuates tau hyperphosphorylation by inhibition of PP2A demethylation

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Yang, Cui Cui ^a   Kuai, Xue Xian ^a,b   Li, Ya Li ^a   Zhang, Li ^a   Yu, Jian Chun ^b   Li, Lin ^a   Zhang, Lan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893729288     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/108486     Document Type: Article

References (34)

1. Chang E., Congdon E. E., Honson N. S., Duff K. E., Kuret J., Structure-activity relationship of cyanine tau aggregation inhibitors. Journal of Medicinal Chemistry 2009 52 11 3539 3547 2-s2.0-66749176089 10.1021/jm900116d
2. Wang J.-Z., Grundke-Iqbal I., Iqbal K., Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. European Journal of Neuroscience 2007 25 1 59 68 2-s2.0-33846212717 10.1111/j.1460-9568.2006.05226.x (Pubitemid 46098893)
3. Hanger D. P., Anderton B. H., Noble W., Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends in Molecular Medicine 2009 15 3 112 119 2-s2.0-61849088424 10.1016/j.molmed.2009.01.003
4. Li B., Chohan M. O., Grundke-Iqbal I., Iqbal K., Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathologica 2007 113 5 501 511 2-s2.0-34247574162 10.1007/s00401-007-0207-8 (Pubitemid 46672596)
5. Noble W., Hanger D. P., Miller C. C., Lovestone S., The importance of tau phosphorylation for neurodegenerative diseases. Frontiers in Neurology 2013 4 83
6. Rodriguez-Martin T., Cuchillo-Ibáñez I., Noble W., Nyenya F., Anderton B. H., Hanger D. P., Tau phosphorylation affects its axonal transport and degradation. Neurobiology of Aging 2013 34 9 2146 2157
7. Boutajangout A., Sigurdsson E. M., Krishnamurthy P. K., Tau as a therapeutic target for alzheimer's disease. Current Alzheimer Research 2011 8 6 666 677 2-s2.0-80051710736 10.2174/156720511796717195
8. Xu G.-G., Deng Y.-Q., Liu S.-J., Li H.-L., Wang J.-Z., Prolonged Alzheimer-like tau hyperphosphorylation induced by simultaneous inhibition of phosphoinositol-3 kinase and protein kinase C in N2a cells. Acta Biochimica et Biophysica Sinica 2005 37 5 349 354 2-s2.0-23844459902 10.1111/j.1745-7270.2005. 00050.x (Pubitemid 41169483)
9. Liu S. J., Zhang A. H., Li H. L., Wang Q., Deng H. M., Netzer W. J., Xu H., Wang J. Z., Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. Journal of Neurochemistry 2003 87 6 1333 1344 2-s2.0-0346434153 (Pubitemid 38020568)
10. Wang Y., Zhang J.-X., Du X.-X., Zhao L., Tian Q., Zhu L.-Q., Wang S.-H., Wang J.-Z., Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3. Journal of Neurochemistry 2008 106 6 2364 2374 2-s2.0-50849130542 10.1111/j.1471-4159.2008. 05578.x
11. Yao X. Q., Li X. C., Zhang X. X., Glycogen synthase kinase-3beta regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1. FEBS Letters 2012 586 16 2522 2528
12. Dou Y. C., Clinical application analysis of cornus officimalis. Journal of Shandong University of Traditional Chinese Medicine 2010 34 4 313 314
13. Liang J. F., Qin C., Advances in traditional Chinese medicine to treat Alzheimer's disease. Shandong Journal of Traditional Chinese Medicine 2010 29 8 576 578
14. Yao R.-Q., Zhang L., Wang W., Li L., Cornel iridoid glycoside promotes neurogenesis and angiogenesis and improves neurological function after focal cerebral ischemia in rats. Brain Research Bulletin 2009 79 1 69 76 2-s2.0-60549114393 10.1016/j.brainresbull.2008.12.010
15. Ya B.-L., Li C.-Y., Zhang L., Wang W., Li L., Cornel iridoid glycoside inhibits inflammation and apoptosis in brains of rats with focal cerebral Ischemia. Neurochemical Research 2010 35 5 773 781 2-s2.0-77953267934 10.1007/s11064-010-0134-2
16. Zhao L.-H., Ding Y.-X., Zhang L., Li L., Cornel iridoid glycoside improves memory ability and promotes neuronal survival in fimbria-fornix transected rats. European Journal of Pharmacology 2010 647 1-3 68 74 2-s2.0-77957312850 10.1016/j.ejphar.2010.08.016
17. Reiniger L., Lukic A., Linehan J., Rudge P., Collinge J., Mead S., Brandner S., Tau, prions and A β: the triad of neurodegeneration. Acta Neuropathologica 2011 121 1 5 20 2-s2.0-78651250496 10.1007/s00401-010-0691-0
18. Georgievska B., Sandin J., Doherty J., AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans. Journal of Neurochemistry 2013 125 3 446 456
19. Takahashi M., Tomizawa K., Kato R., Sato K., Uchida T., Fujita S. C., Imahori K., Localization and developmental changes of τ protein kinase I/glycogen synthase kinase-3 β in rat brain. Journal of Neurochemistry 1994 63 1 245 255 2-s2.0-0028357787 (Pubitemid 24184925)
20. Yoon S. Y., Choi H. I., Choi J. E., Sul C. A., Choi J. M., Kim D. H., Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. Biochemical and Biophysical Research Communications 2007 363 3 811 816 2-s2.0-34848871269 10.1016/j.bbrc.2007.09.060 (Pubitemid 47513702)
21. Bryant J. C., Westphal R. S., Wadzinski B. E., Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory B α subunit. Biochemical Journal 1999 339, part 2 241 246 2-s2.0-0033560729 10.1042/0264-6021:3390241 (Pubitemid 29209953)
22. Tolstykh T., Lee J., Vafai S., Stock J. B., Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. The EMBO Journal 2000 19 21 5682 5691 2-s2.0-0034331359
23. Obulesu M., Venu R., Somashekhar R., Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology. Neurochemical Research 2011 36 8 1329 1335 2-s2.0-79961181323 10.1007/s11064-011-0475-5
24. Meraz-Ríos M. A., Lira-De León K. I., Campos-Peña V., de Anda-Hernández M. A., Mena-López R., Tau oligomers and aggregation in Alzheimer's disease. Journal of Neurochemistry 2010 112 6 1353 1367 2-s2.0-77349118694 10.1111/j.1471-4159.2009.06511.x
25. Osiecka K. M., Nieznanska H., Skowronek K. J., Jozwiak J., Nieznanski K., Tau inhibits tubulin oligomerization induced by prion protein. Biochimica et Biophysica Acta 2011 1813 10 1845 1853 2-s2.0-80051801884 10.1016/j.bbamcr.2011. 06.016
26. Iqbal K., Grundke-Iqbal I., Smith A. J., George L., Tung Y.-C., Zaidi T., Identification and localization of a τ peptide to paired helical filaments of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1989 86 14 5646 5650 2-s2.0-0024312664 (Pubitemid 19185601)
27. Gong C.-X., Liu F., Grundke-Iqbal I., Iqbal K., Post-translational modifications of tau protein in Alzheimer's disease. Journal of Neural Transmission 2005 112 6 813 838 2-s2.0-18544390506 10.1007/s00702-004-0221-0 (Pubitemid 40655573)
28. Liu F., Liang Z., Gong C. X., Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease. Panminerva Medica 2006 48 2 97 108 2-s2.0-33750535186 (Pubitemid 44671265)
29. Hanger D. P., Byers H. L., Wray S., Leung K.-Y., Saxton M. J., Seereeram A., Reynolds C. H., Ward M. A., Anderton B. H., Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. Journal of Biological Chemistry 2007 282 32 23645 23654 2-s2.0-34548191034 10.1074/jbc.M703269200 (Pubitemid 47311907)
30. Lim Y.-W., Yoon S.-Y., Choi J.-E., Kim S.-M., Lee H.-S., Choe H., Lee S.-C., Kim D.-H., Maintained activity of glycogen synthase kinase-3 β despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model. Biochemical and Biophysical Research Communications 2010 395 2 207 212 2-s2.0-77951623547 10.1016/j.bbrc.2010.03.163
31. Qian W., Shi J., Yin X., Iqbal K., Grundke-Iqbal I., Gong C.-X., Liu F., PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3 β Journal of Alzheimer's Disease 2010 19 4 1221 1229 2-s2.0-77950366745 10.3233/JAD-2010-1317
32. Liu F., Grundke-Iqbal I., Iqbal K., Gong C.-X., Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. European Journal of Neuroscience 2005 22 8 1942 1950 2-s2.0-27644478606 10.1111/j.1460-9568.2005.04391.x (Pubitemid 41579384)
33. Martin L., Page G., Terro F., Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3 β Neurochemistry International 2011 59 2 235 250 2-s2.0-79960360530 10.1016/j.neuint.2011.05.010
34. de Baere I., Derua R., Janssens V., Van Hoof C., Waelkens E., Merlevede W., Goris J., Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. Biochemistry 1999 38 50 16539 16547 2-s2.0-0033554835 10.1021/bi991646a (Pubitemid 30007506)